| PSMD12 |
PSMD12: 26S proteasome non-ATPase regulatory subunit 12 |
CFLAR |
CFLAR, CASH, CASP8AP1, CLARP, MRIT: CASP8 and FADD-like apoptosis regulator prec |
0.6 |
Evidence |
|
| TLR4 |
TLR4: Toll-like receptor 4 precursor |
IL1RL1 |
IL1RL1, DER4, ST2, T1: Interleukin-1 receptor-like 1 precursor |
0.6 |
Evidence |
|
| LILRB1 |
IPI00385703 |
SCAP2 |
SKAP2, PRAP, RA70, SAPS, SCAP2, SKAP55R: Src kinase-associated phosphoprotein 2 |
0.6 |
Evidence |
|
| MYBPC2 |
MYBPC2, MYBPCF: Myosin-binding protein C, fast-type |
TTN |
IPI00179357 |
0.6 |
Evidence |
|
| FGL2 |
FGL2: Fibroleukin precursor |
IGSF6 |
IGSF6, DORA: Immunoglobulin superfamily member 6 precursor. |
0.6 |
Evidence |
|
| FGL2 |
FGL2: Fibroleukin precursor |
LILRB2 |
IPI00303952 |
0.6 |
Evidence |
|
| FGL2 |
FGL2: Fibroleukin precursor |
CD302 |
CD302, CLEC13A, DCL1, KIAA0022: CD302 antigen precursor |
0.6 |
Evidence |
|
| GZMM |
GZMM, MET1: Granzyme M precursor |
UNC84B |
UNC84B, FRIGG, KIAA0668, RAB5IP, SUN2: Sad1/unc-84-like protein 2 |
0.6 |
Evidence |
|
| XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
KLRF1 |
IPI00619913 |
0.6 |
Evidence |
|
| XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
KIR2DS2 |
KIR2DS2, CD158J, NKAT5: Killer cell immunoglobulin-like receptor 2DS2 precursor |
0.6 |
Evidence |
|
| XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
KLRC3 |
KLRC3, NKG2E: NKG2-E type II integral membrane protein |
0.6 |
Evidence |
|
| XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
MYOM2 |
MYOM2: Myomesin-2 |
0.6 |
Evidence |
|
| KIR3DL2 |
KIR3DL2, CD158K, NKAT4: Killer cell immunoglobulin-like receptor 3DL2 precursor |
XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
0.6 |
Evidence |
|
| CD96 |
CD96: T-cell surface protein tactile precursor |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
0.6 |
Evidence |
|
| CD96 |
CD96: T-cell surface protein tactile precursor |
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
0.6 |
Evidence |
|
| CCR1 |
CCR1, CMKBR1, CMKR1, SCYAR1: C-C chemokine receptor type 1 |
RGS2 |
RGS2, G0S8: Regulator of G-protein signaling 2 |
0.6 |
Evidence |
|
| HLA-F |
HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec |
RIN3 |
IPI00329749 |
0.6 |
Evidence |
|
| HLA-F |
HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec |
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
0.6 |
Evidence |
|
| KLRK1 |
KLRK1, D12S2489E, NKG2D: NKG2-D type II integral membrane protein |
GZMM |
GZMM, MET1: Granzyme M precursor |
0.6 |
Evidence |
|
| KLRC2 |
KLRC2, NKG2C: NKG2-C type II integral membrane protein |
GZMM |
GZMM, MET1: Granzyme M precursor |
0.6 |
Evidence |
|
| KLRC2 |
KLRC2, NKG2C: NKG2-C type II integral membrane protein |
XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
0.6 |
Evidence |
|
| AGXT |
AGXT, AGT1, SPAT: Serine--pyruvate aminotransferase |
HGFAC |
HGFAC: Hepatocyte growth factor activator precursor |
0.6 |
Evidence |
|
| NEB |
NEB: Nebulin |
MYBPC2 |
MYBPC2, MYBPCF: Myosin-binding protein C, fast-type |
0.6 |
Evidence |
|
| GZMH |
GZMH, CGL2, CTSGL2: Granzyme H precursor |
KLRF1 |
IPI00619913 |
0.6 |
Evidence |
|
| GZMH |
GZMH, CGL2, CTSGL2: Granzyme H precursor |
KLRC3 |
KLRC3, NKG2E: NKG2-E type II integral membrane protein |
0.6 |
Evidence |
|